tradingkey.logo

Bioventus Inc

BVS
7.460USD
+0.080+1.08%
收盘 12/26, 16:00美东报价延迟15分钟
499.62M总市值
47.61市盈率 TTM

Bioventus Inc

7.460
+0.080+1.08%

关于 Bioventus Inc 公司

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.

Bioventus Inc简介

公司代码BVS
公司名称Bioventus Inc
上市日期Feb 11, 2021
CEOClaypoole (Robert E)
员工数量930
证券类型Ordinary Share
年结日Feb 11
公司地址4721 Emperor Boulevard, Suite 100
城市DURHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编27703
电话19194746700
网址https://www.bioventus.com/
公司代码BVS
上市日期Feb 11, 2021
CEOClaypoole (Robert E)

Bioventus Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Ms. Michelle Mcmurry-Heath, M.D., Ph.D.
Independent Director
Independent Director
57.00K
-23.70%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
11.70K
--
Mr. Mark Singleton
Mr. Mark Singleton
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Ms. Katrina Church, J.D.
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
134.37K
+7.98%
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
105.96K
+33.34%
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
100.12K
--
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
85.24K
+45.10%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
79.62K
+74.79%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
76.44K
+53.05%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Pain Treatments and Joint Preservation
73.31M
49.65%
Surgical solutions
52.72M
35.70%
Restorative Therapies
21.64M
14.65%
地区USD
名称
营收
占比
United States
128.78M
87.21%
International
18.89M
12.79%
业务
地区
业务USD
名称
营收
占比
Pain Treatments and Joint Preservation
73.31M
49.65%
Surgical solutions
52.72M
35.70%
Restorative Therapies
21.64M
14.65%

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
8.68%
The Vanguard Group, Inc.
4.30%
其他
47.92%
持股股东
持股股东
占比
EW Healthcare Partners
19.44%
Juniper Investment Company, LLC
10.36%
Smith & Nephew Group plc
9.30%
Nantahala Capital Management, LLC
8.68%
The Vanguard Group, Inc.
4.30%
其他
47.92%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
22.94%
Venture Capital
19.55%
Investment Advisor
15.40%
Hedge Fund
14.00%
Corporation
9.30%
Individual Investor
2.50%
Research Firm
1.72%
Insurance Company
0.47%
Bank and Trust
0.20%
其他
13.93%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
319
49.87M
91.76%
-1.55K
2025Q3
324
49.87M
92.42%
+451.64K
2025Q2
315
49.43M
88.24%
+1.39M
2025Q1
300
47.59M
85.68%
-9.15M
2024Q4
302
46.29M
87.45%
+580.76K
2024Q3
303
45.64M
84.02%
-1.26M
2024Q2
271
47.35M
78.83%
+4.38M
2024Q1
269
42.96M
79.86%
-7.88M
2023Q4
267
41.98M
81.20%
+236.50K
2023Q3
256
41.69M
80.71%
+844.38K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
EW Healthcare Partners
13.02M
19.47%
--
--
Jun 30, 2025
Juniper Investment Company, LLC
6.94M
10.37%
--
--
Jun 30, 2025
Smith & Nephew Group plc
6.23M
9.31%
--
--
Apr 07, 2025
Nantahala Capital Management, LLC
5.28M
7.89%
+1.16M
+28.00%
Jun 30, 2025
The Vanguard Group, Inc.
2.77M
4.14%
+223.28K
+8.77%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.82M
4.21%
+259.59K
+10.15%
Jun 30, 2025
Royce Investment Partners
1.09M
1.63%
+199.86K
+22.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.05M
1.58%
+122.14K
+13.09%
Jun 30, 2025
American Century Investment Management, Inc.
1.12M
1.68%
+79.83K
+7.64%
Jun 30, 2025
Kent Lake PR LLC
350.04K
0.52%
+350.04K
--
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Vanguard US Multifactor ETF
0.1%
VictoryShares Small Cap Free Cash Flow ETF
0.1%
Harbor Human Capital Factor US Small Cap ETF
0.09%
Fidelity Enhanced Small Cap ETF
0.09%
iShares Micro-Cap ETF
0.06%
Principal U.S. Small-Cap ETF
0.05%
Vanguard US Value Factor ETF
0.04%
Humankind US Stock ETF
0.03%
WisdomTree US SmallCap Fund
0.03%
Avantis US Small Cap Value ETF
0.03%
查看更多
Vanguard US Multifactor ETF
占比0.1%
VictoryShares Small Cap Free Cash Flow ETF
占比0.1%
Harbor Human Capital Factor US Small Cap ETF
占比0.09%
Fidelity Enhanced Small Cap ETF
占比0.09%
iShares Micro-Cap ETF
占比0.06%
Principal U.S. Small-Cap ETF
占比0.05%
Vanguard US Value Factor ETF
占比0.04%
Humankind US Stock ETF
占比0.03%
WisdomTree US SmallCap Fund
占比0.03%
Avantis US Small Cap Value ETF
占比0.03%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Bioventus Inc的前五大股东是谁?

Bioventus Inc 的前五大股东如下:
EW Healthcare Partners持有股份:13.02M,占总股份比例:19.47%。
Juniper Investment Company, LLC持有股份:6.94M,占总股份比例:10.37%。
Smith & Nephew Group plc持有股份:6.23M,占总股份比例:9.31%。
Nantahala Capital Management, LLC持有股份:5.28M,占总股份比例:7.89%。
The Vanguard Group, Inc.持有股份:2.77M,占总股份比例:4.14%。

Bioventus Inc的前三大股东类型是什么?

Bioventus Inc 的前三大股东类型分别是:
EW Healthcare Partners
Juniper Investment Company, LLC
Smith & Nephew Group plc

有多少机构持有Bioventus Inc(BVS)的股份?

截至2025Q4,共有319家机构持有Bioventus Inc的股份,合计持有的股份价值约为49.87M,占公司总股份的91.76%。与2025Q3相比,机构持股有所增加,增幅为-0.66%。

哪个业务部门对Bioventus Inc的收入贡献最大?

在FY2025Q2,Pain Treatments and Joint Preservation业务部门对Bioventus Inc的收入贡献最大,创收73.31M,占总收入的49.65%。
KeyAI